Your browser doesn't support javascript.
loading
Development of new therapeutic strategies in gynecological cancers in Iran by utilizing xenograft model of ovarian adenocarcinoma
Journal of Family and Reproductive Health. 2010; 4 (3): 105-107
in En | IMEMR | ID: emr-113420
Responsible library: EMRO
To evaluate the potentiality of OVCAR-3 cell line of ovarian adenocarcinoma as a xenograft model for ovarian adenocarcinoma in nude mice. The cell line isolated from advanced human ovarian adenocarcinoma, were inoculated to eight nude mice and two months later. Established tumors were transferred to pathology laboratory to be prepared by H and E staining and immunohistochemical staining with CA125 antibody. Study of H and E slides showed advanced adenocarcinoma. The CA125 Tumor marker was also positive in tumoral tissue. Established tumors showed excellently the characteristics of ovarian adenocarcinoma. This model can be used to evaluate new treatment strategies
Search on Google
Index: IMEMR Type of study: Prognostic_studies Language: En Journal: J. Fam. Reprod. Health Year: 2010
Search on Google
Index: IMEMR Type of study: Prognostic_studies Language: En Journal: J. Fam. Reprod. Health Year: 2010